別品名 |
E-64c ethyl ester; EP 453; EST; Loxistatin
|
純度 |
greater than or equal to 95% (HPLC)
|
分子量 |
342.4
|
CAS RN® |
88321-09-9
|
構造 |
C17H30N2O5
|
溶媒 |
DMSO (20mg/ml), DMF (20mg/ml) or ethanol (5mg/ml)
|
形状 |
凍結乾燥品
|
使用目的 |
Aloxistatin [E-64d] is a cell permeable irreversible inhibitor of lysosomal and cytosolic cysteine proteases cathepsin B an L, calpain 1/2, papain and has diverse biological activities. It is an ethyl ester form of E-64c that inhibits calpain and the cysteine proteases cathepsins F, K, B, H, and L.
Aloxistatin has anticancer properties by inducing cell cycle arret at the G2/M phase in A431 human epidermoid carcinoma cells and as a lysosomal inhibitor in human acute promyelocytic leukemia NB4 cells and Huh-7 cells. It inhibits degradation of autophagic cargo inside autolysosomes.
It also shows neuroprotective and anti-malarial properties.
Since cysteine protease cathepsin L is required for SARS-CoV-2 viral entry, aloxistatin treatment reduces cellular entry of SARS-CoV-2 pseudovirions and COVID-19. It inhibits severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 surface glycoprotein incorporation into pseudotyped vesicular stomatitis virus (VSV) particles in Vero cells. Is has been applied in vitro in combination with the TMPRSS2 inhibitor camostat mesylate (Prod. No. AG-CR1-3716).
|
|
メーカー |
品番 |
包装 |
PSC
|
11-077
|
5 MG [5 mg]
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
3週間程度
|
保存温度 |
-20℃
|
|